Goldman Sachs Small/Mid Cap Growth R holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Goldman Sachs Small/Mid Cap Growth Fund Class R GTMRX
- NAV / 1-Day Return $17.41 / −2.79 %
- Fund Size $1.1B
- Adjusted Expense Ratio 1.500%
- Net Expense Ratio 1.500%
- Fee Level: Distribution High
- Share Class Type Retirement, Medium
- Morningstar Category Mid-Cap Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 105%
Morningstar’s Analysis GTMRX
Will GTMRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
MACOM Technology Solutions Holdings Inc | 2.65 | 30M | Technology |
Lattice Semiconductor Corp | 2.32 | 26M | Technology |
Onto Innovation Inc | 2.00 | 23M | Technology |
Guardant Health Inc | 1.95 | 22M | Healthcare |
Roivant Sciences Ltd Ordinary Shares | 1.95 | 22M | Healthcare |
Everpure Inc Class A | 1.93 | 22M | Technology |
SiTime Corp Ordinary Shares | 1.84 | 21M | Technology |
BrightSpring Health Services Inc | 1.78 | 20M | Healthcare |
Halozyme Therapeutics Inc | 1.72 | 20M | Healthcare |
ATI Inc | 1.68 | 19M | Industrials |